Fig. 2From: Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trialTherapy schedule and endpoints of the studyBack to article page